Microsatellite and Mini-Exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole

Vector-Borne and Zoonotic Diseases

Volumn 13, Issue 3, 2013, Pages 181-187

  Martínez, Ignacio ^a   Nogueda, Benjamín ^b   Martínez Hernández, Fernando ^c   Espinoza, Bertha ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

Benznidazole; Chagas disease; Genetics; Nifurtimox; Trypanosome

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX;

ALLELE; ARTICLE; DRUG SENSITIVITY; EPIMASTIGOTE; EXON; GENE LOCUS; GENOTYPE; HUMAN; IC 50; IN VITRO STUDY; MAMMAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; CHAGAS DISEASE; DNA, PROTOZOAN; DRUG RESISTANCE; EXONS; GENETIC VARIATION; GENOTYPE; HUMANS; INSECT VECTORS; MEXICO; MICROSATELLITE REPEATS; NIFURTIMOX; NITROIMIDAZOLES; OPOSSUMS; PHYLOGENY; POLYMERASE CHAIN REACTION; TRIATOMA; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84875163847     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2012.1072     Document Type: Article

References (39)

1. Añez, N, Crisante, G, da Silva, FM, Rojas, A, et al. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagaś disease. Trop Med Int Healt 2004; 9:1319-1326
2. Arantes, JM, Francisco, AF, de Abreu, VPM, Silva, M, et al. Trypanosoma cruzi: Desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect. Exp Parasitol 2011; 128:401-408
3. Barnabé, C, De Meus, T, Noireau, F, Bosseno, MF, et al. Trypanosoma cruzi discrete typing units (DTUs): Nicrosatellite loci and population genetics of DTUs TcV and TcI in Bolivia and Peru. Inf Gen Evol 2011; 11:1752-1760
4. Bosseno, MF, Barnabé, C, Magallon, E, Lozano, F, et al. Predominance of Trypanosoma cruzi lineage I in Mexico. J Clin Microbiol 2002; 40:627-632
5. Bosseno, MF, Barnabé, C, Rami'rez-Sierra, MJ, Kengne, P, et al. Wild ecotopes and food habits of Triatoma longipennis infected by Trypanosoma cruzi lineages I and II in Mexico. Am J Trop Med Hyg 2009; 80:988-991
6. Cinque, GM, Szajnman, SH, Zhong, L, Docampo, R, et al. Structure-Activity relationship of new growth inhibitors of Trypanosoma cruzi. J Med Chem 1998; 41:1540-1554
7. Falla, A, Herrera, C, Fajardo, A, Montilla, M, et al. Haplotype identification within Trypanosoma cruzi I in Colombian isolates from several reservoirs, vectors and humans. Acta Trop 2009; 110:15-21
8. Galavi'z-Silva, L, Molina-Garza, DP, Gonza'lez-Santos, MA, Mercado-Herna'ndez, R, et al. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico. Am J Trop Med Hyg 2009; 81: 404-406
9. Gomes, ML, Ornelas, M, Vataru, C, Rodri'guez, N, et al. Trypanosoma cruzi: Genetic group with peculiar biochemical and biological behavior. Mem Inst Oswaldo Cruz 2003; 98:649-654
10. Go'mez-Herna'ndez, C, Resende-Oliveira, K, Nogueira, G, Rocha, L, et al. Molecular characterization of Trypanosoma cruzi Mexican strains and their behavior in the mouse experimental model. Rev Soc Bras Med Trop 2011; 44:684-690
11. Huelsenbeck, JP, Ronquist, F, Nielsen, R, Bollback, JP. Bayesian inference of phylogeny and its impact on evolutionary biology. Science 2001; 294:2310-2231
12. Jacobs, T, Bruhn, H, Gaworski, I, Fleischer, B, et al. NK-lysin and its shortened analog NK-2 exhibit potent activities against Trypanosoma cruzi. Antimicrob Agents Chemother 2003; 47:607-613
13. Leo'n-Pe'rez, F, Go'mez-Garci'a, L, Alejandre-Aguilar, R, Ló pez, R, et al. Mexican Trypanosoma cruzi isolates: In vitro susceptibility of epimastigotes to anti-Trypanosoma cruzi drugs and metacyclic forms to complement-mediated lysis. Vector Borne Zoonot Dis 2007; 7:330-336
14. Llewellyn, MS, Miles, MA, Carrasco, HJ, Lewis, MD, et al. Genome-scale multilocus microsatellite typing of Trypanosoma cruzi discrete typing unit I reveals phylogeographic structure and specific genotypes linked to human infection. PLOS Path 2009; 5: E1000410
15. Lo'pez-Olmos, V, Pe'rez-Nasser, V, Piñero, D, Ortega, E, et al. Biological characterization and genetic diversity of Mexican isolates of Trypanosoma cruzi. Acta Trop 1998; 69:239-254
16. Luna, KP, Herna'ndez, IP, Rueda, CM, Zorro, MM, et al. In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole. Biome'dica 2009; 29:448-455
17. Macedo, AM, Martins, MS, Chiari, E, Pena, SDJ. DNA fingerprint of Trypanosoma cruzi: A new tool for characterization of strains and clones. Mol Biochem Parasitol 1992; 55:147-154
18. Macedo, AM, Pimenta, J, Aguiar, R, Melo, A, et al. Usefulness of microsatellite typing in population genetic studies of Trypanosoma cruzi. Mem Inst Oswaldo Cruz 2001; 96:407-413
19. Meji'a-Jaramillo, AM, Ferna'ndez, GJ, Palacio, L, Triana-Cha'vez, O. Gene expression study using real-Time PCR identifies an NTR gene as a major marker of resistance to benznidazole in Trypanosoma cruzi. Parasite Vector 2011; 4:169-181
20. Mezencev, R, Galizzi, M, Kutschy, P, Docampo, R. Trypanosoma cruzi: Antiproliferative effect of indole phytoalexins on intracellular amastigotes in vitro. Exp Parasitol 2009; 122:66-69
21. Murta, SMF, Gazzinelli, RT, Brener, Z, Romanha, AJ. Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox. Mol Biochem Parasitol 1998; 93:203-214
22. Murta, SMF, Krieger, MA, Montenegro, LR, Campos, et al. Deletion of copies of the gene encoding old yellow enzyme (TcOYE), a NAD(P)H flavin oxidoreductase, associates with in vitro-induced benznidazole resistance in Trypanosoma cruzi. Mol Biochem Parasitol 2006; 146:151-162
23. Nirdé, P, Larroque, C, Barnabé, C. Drug-resistant epimastigotes of Trypanosoma cruzi and persistence of this phenotype after differentiation into amastigotes. C R Acad Sci III 1995; 318:1239-1244
24. Ocaña-Mayorga, S, Llewellyn, MS, Costales, JA, Miles, MA, et al. Sex, subdivision, and domestic dispersal of Trypanosoma cruzi lineage I in southern Ecuador. PLOS Neg Trop Dis 2010; 4:e915. doi:10.1371/journal.pntd. 0000915
25. Oliveira, RP, Broude, N, Macedo, AM, Cantor, CR, et al. Probing the genetic population structure of Trypanosoma cruzi with polymorphic microsatellites. Proc Natl Acad Sci USA1998; 95:3776-3780
26. Rangel-Flores, H, Sa'nchez, B, Mendoza-Duarte, J, Barnabé, C, et al. Serologic and parasitologic demonstration of Trypanosoma cruzi infections in an urban area of central Me'xico: Correlation with electrocardiographic alterations. Am J Trop Med Hyg 2001; 65:887-895
27. Risso, M, Sartor, P, Burgos, J, Briceño, L, et al. Immunological identification of Trypanosoma cruzi lineages in human infection along the endemic area. Am J Trop Med Hyg 2011; 84: 78-84
28. Rui'z-Sa'nchez, R, de Leó n, MP, Matta, V, Reyes, PA, et al. Trypanosoma cruzi isolates from Mexican and Guatemalan acute and chronic chagasic cardiopathy patients belong to Trypanosoma cruzi I. Mem Inst Oswaldo Cruz 2005; 100:281-283
29. Schneider, S, Roessli, D, Excoffier, L. Arlequin ver. 2.000: A software for population genetics data analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland. 2000
30. Souto, RP, Fernandes, O, Macedo, AM, Campbell, DA, et al. DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Mol Biochem Parasitol 1996; 83:141-152
31. Toledo, MJO, Bahia, MT, Carneiro, CM, Martins-Filho, OA, et al. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents Chemother 2003; 47:223-230
32. Velasco-Castrejó n, O, Valdespino, JL, Tapia-Conyer, R, Salvatierra, B, et al. Seropepidemiología de la enfermedad de Chagas en México. Salud Pú blica Mex 1992; 34:186-196o
33. Vieites, M, Otero, L, Santos, D, Toloza, J, et al. Platinum (II) metal complexes as potential anti-Trypanosoma cruzi agents. J Inorg Biochem 2008; 102:1033-1043
34. Villarreal, D, Barnabé, C, Sereno, D, Tibayrenc, M. Lack of correlation between in vitro susceptibility to benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagaś disease. Exp Parasitol 2004; 108:24-31
35. Villarreal, D, Nirdé, P, Hide, M, Barnabé, C, et al. Differential gene expression in benznidazole-resistant Trypanosoma cruzi parasites. Antimicrobial Agents Chemother 2005; 49:2701-2709
36. Wilkinson, SR, Taylor, MC, Horn, D, Kelly, JM, et al. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc Natl Acad Sci USA 2008; 105:5022-5027
37. World Health Organization 2010. First WHO report on neglected tropical diseases 2010: Working to overcome the global impact of neglected tropical diseases. ISBN 978 92 4 1564090, Geneva, Switzerland
38. Zaverucha, T, Calabrese, KS, Cô rte-Real, S, Baetas, WC, et al. Trypanosoma cruzi: In vitro morphological alterations induced by actinomycin D. Pharmacology 2003; 67:55-58
39. Zingales, B, Andrade, SG, Briones, MRS, Campbell, DA, et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: Second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 2009; 104:1051-1054